Technetium Tc-99m tilmanocept Completed Phase 1 Trials for Carcinoma, Colorectal / Hepatic Metastases Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic1
clinicaltrials.gov IdentifierTitleDrugs
NCT03029988An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.